Vietnam: New Decree On The Promulgation Of The Law On Pharmacy In Vietnam

Last Updated: 20 December 2017
Article by Bui Ngoc Duong

Issuance

The Government of Socialist Republic of Vietnam issued new Decree No. 54/2017/ND-CP on May 08, 2017 ("new Decree") on detailing some articles and guiding implementation of Law on Pharmacy [[1]] ("new Law"). The new Decree will take effect as from July 01, 2017, and shall apply to domestic and foreign agencies, organizations and individuals involving pharmacy activities in Vietnam.

The new Decree consists of nine sections of General Provisions; Certificates of Pharmaceutical Practice; Pharmaceutical Business; Drug and Materials Export and Import; Registration for Raw Medicinal Materials, Expedient, Capsule Marketing Authorization and Evaluation on Foreign Drug Manufacturing Facilities; Authority, Form and Procedures to revoke raw medicinal materials, Treatment for revoked raw medicinal materials; Dossiers, Evaluation Procedures and Authority for issuing the confirmation on Drug Advertisements; Drug Price Management; and Implementation Provisions.

This update will focus on the key points which may be involved activities in Vietnam of foreign pharmaceutical companies and/or manufacturers.

Pharmacy Business

Pharmacy Business Activities

Under the new Law and the new Decree, the following activities should be considered as pharmacy business:

  • Trading of drugs, raw medicinal materials;
  • Providing services on storage of drugs, raw medicinal materials;
  • Providing services on testing of drugs, raw medicinal materials;
  • Providing services on clinical trial of drugs;
  • Providing services on bioequivalence study of drugs.

Pharmacy Business Entities would be included:

  • Manufacturing facilities of drugs, raw medicinal materials;
  • Exporters, importers of drugs, raw medicinal materials;
  • Providers of services on storage of drugs, raw medicinal materials;
  • Wholesalers of drugs, raw medicinal materials;
  • Retailers of drugs, namely drug shops, dispensaries of hospitals, medical stations of communes, retailers of herbal ingredients, herbal medicine, traditional medicine;
  • Providers of services on testing of drugs, raw medicinal materials;
  • Providers of services on clinical trial of drugs;
  • Providers of services on bioequivalence study of drugs.

The Agents for selling/ distribution of drugs on behalf of other pharmacy business entities under the old regulations have not been mentioned and regulated in the new Law and the new Decree.

Certificate of Pharmacy Business Eligibility

Certificate of Pharmacy Business Eligibility ("Certificate") is the prerequisites to operate in the pharmaceutical business sector in Vietnam. Department of Health under Provinces/ Central Cities should evaluate dossier and issue Certificate for only wholesalers and retailers of drugs. Meanwhile, Ministry of Health ("MOH") must focus on the balance pharmacy business entities and grant the Certificate regarding manufacture, import, export, services on storage, testing, clinical trial and bioequivalence study of drugs.

License for foreign companies conducting operations in medicines and raw medicinal materials in Vietnam ("Trading License") had been removed from the new Law. In case any foreign entity is only focused on getting Marketing Authorization for drugs ("Visa"), it can establish a Representative Office in Vietnam and then a certified copy of the valid Certificate of Representative Office can be enclosed for each Visa application dossier instead of the Trading License as previous regulations.

Import Rights for Foreigners

It is noteworthy that under WTO Commitments during the accession of Vietnam in the year of 2006, foreign pharmaceutical agencies, organizations and individuals do not conduct direct distribution of medicines in Vietnam in any way. The new Law is still kept this strictly regulation. However, the new Decree opens the door in which foreign entity has rights as an importer of drugs, raw medicinal materials in Vietnam.

In order to operate as an importer of drugs, raw medicinal materials directly from foreign countries into Vietnam, foreign pharmacy entity should get Certificate of Pharmacy Business Eligibility for importer.

The requirements for issuance of this Certificate include: the importer must have the proper location in Vietnam, drug storage, storage equipment, transportation, quality control system, technical documents and personnel in accordance with Good Storage Practice ("GSP") requirements.

Under the new Decree, foreign importer whom can be considered as an entity has the right to import but cannot exercise the right to distribute drugs and medicinal materials in Vietnam shall have to notify in writing to the MOH of the wholesalers to distribute imported drugs and raw medicinal materials into Vietnam before selling drugs or stop selling drugs to that entity.

The new Decree also stipulates strict prohibition of the distribution rights of foreign pharmacy entities. Accordingly, entities having the right to import but not being permitted to distribute drugs and raw medicinal materials in Vietnam MUST NOT carry out the FOLLOWING ACTIVITIES directly related to the distribution of drugs and raw medicinal materials in Vietnam (except for drugs and raw medicinal materials produced by themselves in Vietnam):

  • selling drugs, raw medicinal materials, delivery of drugs, raw medicinal materials for healthcare facilities (hospital, clinics), retailers and end-users that are not wholesalers of drugs and raw medicinal materials,
  • receiving order and payment from healthcare facilities (hospital, clinics), retailers and end-users,
  • delivering, storing of drugs and raw medicinal materials,
  • establishing price policy of distributors,
  • determining distribution and trading pathway of distributors,
  • building supply plan of drugs and raw medicinal materials of hospital and clinics,
  • providing financial support under any form to manipulate the distribution of drugs and raw medicinal materials,
  • other activities related to drugs distribution.

General requirements for Export and Import of Drugs

Export

Drugs and raw medicinal materials may be exported without being licensed by the MOH, except for herbal ingredients on the List of controlled rare and special herbs, controlled drugs, medicinal ingredients that are psychotropic, narcotic ingredients, or precursors defined by the MOH, or radioactive substances on the List promulgated by the Government.

Import

Drugs, raw medicinal ingredients that already granted Visa in Vietnam, may be imported without import permit licences from MOH, except for the special controlled drugs.

The Decree also stipulates requirements and procedures for import permit licenses ("Quota") for drugs that are without Visa, or under special control and have other special purposes, such as parallel import.

For drugs including active ingredients without Visa or drugs containing substances to be first-time used in Vietnam, it may be granted the Quota if the following conditions should be met:

  • Drugs must be licensed for circulation (Visa) in one of the following countries: the manufacturing country, reference country is a member country of The International Council for Harmonization of Technical Requirements for Human Use (ICH) or Australia;
  • Drugs must be used for life-threatening disease, social disease, dangerous and emerging diseases promulgated by the MOH;
  • Drug must have full clinical trial on safety and efficacy; vaccine must undergo local clinical trial as being set out in registration regulations.

Regarding drugs containing active ingredients already granted Visa in Vietnam but not meeting the demand for treatment yet and drugs containing substances already used as drug in Vietnam but does not meeting the demand for treatment yet, the Quota may be granted for that drugs if it meets the following requirements:

  • Belong to the list of drugs which have not met the treatment demands yet promulgated by the MOH;
  • To be licensed for circulation (Visa) in one of the following countries: the manufacturing country, the reference country is a member country of ICH or Australia.

For drugs having similar brand name, active ingredients, content or concentration, dosage forms compared with the original medicines already granted Visa in Vietnam, produced by the original manufacturer or by the authorized manufacturer, and having price lower than the original patent medicine used in Vietnam ("parallel import"), the Quota may be issued for that drugs in case the following criteria should be satisfied:

  • That drugs serves a health program of the State of Vietnam;
  • The expected wholesale price of that drugs should be at least 20% lower than the tender price of the original patent medicine granted Visa in Vietnam;
  • Licensed for circulation of that drugs and export to Vietnam from the country of production or reference country which is ICH member or Australia;
  • Not being radioactive drug, vaccine or biological product.

Remaining Self-Life of Drugs at Custom Clearance

Drugs granted the Quota under all kinds as mentioned above must have the minimum remaining self-life at the time of customs clearance as follows:

  • 18 months for drugs or raw medicinal materials with the use duration of more than 24 months;
  • Half of the use duration for drugs or raw medicinal materials with the use duration of 24 months or less.

Sale Contract signed between a foreigner and an entity having the right to import in Vietnam

In case the entity supplying drugs, raw medicinal materials is the foreign entity ("Supplier") to be signed a sale contract with an entity having the right to import in Vietnam ("Importer"). The Supplier must belong to one of the followings:

  1. the manufacturer of that imported drugs, raw medicinal materials,
  2.      the holder of that product or of circulation license of imported drugs, raw medicinal materials whom mentioned in details on the Certificate of Pharmaceutical Products ("CPP"),
  3.    the application entity of Visa in Vietnam which is still valid at the time of customs clearance but not the entity as prescribed at item i) and ii) above,
  4.      the entity has been granted Trading License in Vietnam,

In case the entities are mentioned at items iii) and iv) above, they must be authorized in writing by the entities as defined at items i) and ii) above in order to supply drugs into Vietnam.

The authorization documents may be a power of attorney or a sales permit or partnership certificate. The authorization documents must be in Vietnamese or English and have at least the following information: name and address of the authorizer and the authorized entity; scope of authorization including the supply of drugs and raw medicinal materials into Vietnam; duration of authorization or time limit for sale; the responsibilities of the parties to ensure the quality and origins of drugs and raw medicinal materials supplying into Vietnam; signature of the parties.

Evaluation of Foreign Manufacturing Facilities

Cases to be evaluated

The new Decree stipulates the following cases should be submitted the documents for assessment of foreign manufacturing facilities of drugs and raw medicinal materials when filing application dossiers for Visa in Vietnam:

  1. For drugs and raw medicinal materials not granted Visa, during submission of the application dossier, the application company must submit the documents for assessment of foreign manufacturing facilities in accordance with GMP in the following cases:

    1. first-time foreign manufacturing facilities that have drugs to be submitted for Visa in Vietnam;
    2. drugs manufactured on the production lines not yet evaluated by the MOH;
    3. raw medicinal materials are first-time active ingredients to be submitted for Visa in Vietnam;
    4. first-time foreign manufacturing facilities that have pharmaceutical preparations to be submitted for Visa in Vietnam.
  2. For drugs and raw medicinal materials already granted Visa prior to the effective date of this Decree but manufacturing facilities of drugs and raw medicinal materials have not been assessed by the MOH, the application company must submit the documents for assessment of manufacturing facilities in accordance with GMP in the following cases:

    1. When submission of application dossiers for extension of Visa for drugs and raw medicinal materials;
    2. When submission of application dossiers for Visa for drugs and raw medicinal materials due to relocation of manufacturing facilities.

Methods of Evaluation

When a foreign application company and/or manufacturer submits an application dossier for Visa of drugs or raw medicinal materials in Vietnam, its foreign manufacturing facility must be evaluated the GMP requirements by using any of the following methods:

  1. Assessing documents on manufacturing conditions for manufacturing facility except for case mentioned in item 2 or item 3. b) below;
  2. Mutual recognition of inspection results given by pharmacy authorities regarding the fulfilments of GMP requirements shall apply to the following cases:

    1. Manufacturing facilities belonging to countries that are promulgated by the MOH in the list of countries where Vietnam has signed international treaties on mutual recognition of results of GMP's inspection, except for cases specified in item 3 below;
    2. Manufacturing facilities belonging to ICH member countries, Australia and are monitored and assessed by one of thepharmaceutical management agencies of US (US Food and Drug Administration, USFDA), European Union (European Union, European Medicines Agency (EMA)), Australia (Therapeutic Goods Administration, (TGA)), Japan (Pharmaceuticals and Medical Devices Agency, PMDA) or Canada (Health Canada) on compliance with good manufacturing practices, except for cases specified in item 3 below.
  3. On-site inspection at manufacturing facilities shall apply to the following cases:

    1. Manufacturing facility has application dossiers for Visa of drugs and medicinal materials which are found out to have signs of tampering or doubts about the truthfulness of the document's information and data;
    2. Manufacturing facilities has drugs which violated in level 1 on quality according to the MOH's conclusion;
    3. Manufacturing facilities has documents for evaluation of production conditions which has insufficient grounds to prove that these establishments satisfy GMP requirements according to the MOH conclusion.

Duration for Evaluation

The MOH shall receive documents for evaluation of GMP for the foreign manufacturing facilities, and make evaluation reports and notify the results of evaluation of the satisfaction of GMP within the following time limits:

  1. 30 days from the date of receipt of complete documents in the case of evaluation in the form of recognition or recognition of the inspection and examination results of the pharmaceutical state administration agency for requirements of satisfaction of GMP;
  2. 60 days from the date of receipt of complete documents in the case of evaluation in the form of appraisal of documents relating to production conditions;
  3. 90 days from the date of receipt of full documents in the case manufacturing facilities has drugs which violated in level 1 on quality according to the MOH's conclusion.

Control of Drug Price

Under the new Circular, pharmacy business entities cannot sell drugs if the prices declared or re-declared by drug manufacturers or entities ordering the drug-processing or drug-importing entities are not published on the Web Portal of the MOH.

The new Circular also provide stricter requirements in case of increasing drug price: Manufacturer/importer/distributor must provide justification on drug efficacy, comparison between cost and effectiveness, technology evidence and cost breakdown of the drug price.

Some key points for price declaration of drugs imported from foreign countries to Vietnam are as follows:

  1. First of all, the drugs importer should make declaration for the estimated wholesale price and retail price (in case it's necessary to declare the retail price) before introducing the first batch of drugs of this institution to Vietnam's market. For the continuing import shipments, the importer would not be required to make declaration if there is no adjustment for the estimated wholesale and retail price of drugs declared by that institution;
  2. The drugs importer must re-declare the estimated wholesale and retail price when there is the demand for increasing the estimated wholesale and retail price of drugs declared by that institution, re-declare the previous drugs published on the Web Portal of the MOH.

Conclusion

The MOH is currently drafting a considerable number of Circular related to guideline the implementation of the new Decree. As such, the information contained in this material will be updated by Duong & Partners whenever any new legal regulation is issued. This material and all updated materials thereof are available in the firm website.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

    Disclaimer

    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

    Registration

    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

    Cookies

    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

    Links

    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

    Mail-A-Friend

    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

    Emails

    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

    Security

    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions